Arm Holdings plc Reports Results for the Third Quarter of the Fiscal Year Ending 2026

Arm Holdings plc (NASDAQ: ARM), the company that is building the future of computing, has today published a letter to its shareholders containing the company's results for its third quarter of fiscal year 2026, which ended Dec. 31, 2025. The letter is available on its investor relations website ( https://investors.arm.com/financials/quarterly-annual-results ). The shareholder letter will also be furnished to the Securities and Exchange Commission (SEC) on a Form 6-K and will be available on the SEC website at http://www.sec.gov .

Arm will host an audio webcast to discuss its results at 14:00 PT / 17:00 ET / 22:00 GMT today, Feb. 4. The live webcast will be available at https://edge.media-server.com/mmc/p/o443v7p2 and a replay will be at https://investors.arm.com/financials/quarterly-annual-results .

About Arm

Arm is the industry's highest-performing and most power-efficient compute platform with unmatched scale that touches 100 percent of the connected global population. To meet the insatiable demand for compute, Arm is delivering advanced solutions that allow the world's leading technology companies to unleash the unprecedented experiences and capabilities of AI. Together with the world's largest computing ecosystem and 22 million software developers, we are building the future of AI on Arm.

All information is provided "as is" and without warranty or representation. This document may be shared freely, attributed and unmodified. Arm is a registered trademark of Arm Limited (or its subsidiaries or affiliates). All brands or product names are the property of their respective holders. © 1995-2026 Arm Limited.

Media
Kristen Ray
Kristen.Ray@arm.com

Investors
Arm Investor Relations
Investor.Relations@arm.com

News Provided by Business Wire via QuoteMedia

ARM
The Conversation (0)
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT at ASCO 2026

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT at ASCO 2026

Final Phase 2 Bria-IMT median overall survival (OS) is 16.6 months (with Phase 3 formulation) Positive Quality of Life (QOL) data from the ongoing Phase 3 study in heavily pre-treated metastatic breast cancer (MBC) patientsBiomarker analyses from the ongoing Phase 3 study confirm predictors of... Keep Reading...
Allied Critical Metals Announces Corporate Update and Operational Update

Allied Critical Metals Announces Corporate Update and Operational Update

Key Highlights: Allied is fully funded for the next 12 months with over $45 million in cash liquidity. The Company secured a transformational U.S.$40 million financing and tungsten off-take agreement with U.S.$1,000/mtu floor price. First tungsten concentrate production targeted for Q4 2026,... Keep Reading...
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7

KELOWNA, BC / ACCESS Newswire / May 19, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, is pleased to announce that ethics approval has been received from an independent review board, for Human Pilot Study #7... Keep Reading...
Apex Resources Grants Option to Fortress Strategic Metals to Explore and Mine Tungsten Zones in The Jersey-Emerald Project in BC and Appointment of Officer

Apex Resources Grants Option to Fortress Strategic Metals to Explore and Mine Tungsten Zones in The Jersey-Emerald Project in BC and Appointment of Officer

Apex Resources Inc. (TSXV: APX,OTC:SLMLF) (OTCID: SLMLF) ("Apex" or the "Company") is pleased to announce that on May 15, 2026, it entered into a mining option agreement (the "Option Agreement") with Fortress Strategic Metals Corp. ("Fortress"), a private company at arm's length to the Company,... Keep Reading...
Syntholene Energy Corp. Appoints HY Lee to Advisory Board and Grant Tanaka as Corporate Secretary

Syntholene Energy Corp. Appoints HY Lee to Advisory Board and Grant Tanaka as Corporate Secretary

Mr. Lee Served as Contract Director of Barakah Nuclear Energy Plant, One of the Very Few Modern Nuclear Projects to Meet its Original Schedule and Cost TargetsSyntholene Energy Corp (TSXV: ESAF) (OTCQB: SYNTF) (FSE: 3DD0) announces today that HY Lee has been appointed to the Company's Advisory... Keep Reading...

Interactive Chart

Latest Press Releases

Related News